{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:47:01Z","timestamp":1793191621295,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00424-014-1454-x","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T01:17:17Z","timestamp":1393204637000},"page":"757-765","source":"Crossref","is-referenced-by-count":72,"title":["T-type calcium channel blockers as neuroprotective agents"],"prefix":"10.1007","volume":"466","author":[{"given":"Benjamin J.","family":"Kopecky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"issue":"6","key":"1454_CR1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0026-895X(24)13283-X","volume":"53","author":"C Arnoult","year":"1998","unstructured":"Arnoult C, Villaz M, Florman HM (1998) Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells. Mol Pharmacol 53(6):1104\u20131111","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1454_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10059-010-0106-z","volume":"30","author":"J Bae","year":"2010","unstructured":"Bae J, Suh EJ, Lee C (2010) Interaction of T-type calcium channel Ca(V)3.3 with the beta-subunit. Mol Cells 30(3):185\u2013191. doi: 10.1007\/s10059-010-0106-z","journal-title":"Mol Cells"},{"issue":"4","key":"1454_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1472-8206.2010.00879.x","volume":"25","author":"M Bancila","year":"2011","unstructured":"Bancila M, Copin JC, Daali Y, Schatlo B, Gasche Y, Bijlenga P (2011) Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats. Fundam Clin Pharmacol 25(4):469\u2013478. doi: 10.1111\/j.1472-8206.2010.00879.x","journal-title":"Fundam Clin Pharmacol"},{"key":"1454_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.heares.2013.06.004","volume":"304","author":"J Bao","year":"2013","unstructured":"Bao J, Hungerford M, Luxmore R, Ding D, Qiu Z, Lei D, Yang A, Liang R, Ohlemiller KK (2013) Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss. Hear Res 304:33\u201340. doi: 10.1016\/j.heares.2013.06.004","journal-title":"Hear Res"},{"issue":"1\u20133","key":"1454_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2005.08.017","volume":"521","author":"ME Barton","year":"2005","unstructured":"Barton ME, Eberle EL, Shannon HE (2005) The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Pharmacol 521(1\u20133):79\u201385. doi: 10.1016\/j.ejphar.2005.08.017","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1454_CR6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuron.2009.05.015","volume":"62","author":"MP Beenhakker","year":"2009","unstructured":"Beenhakker MP, Huguenard JR (2009) Neurons that fire together also conspire together: is normal sleep circuitry hijacked to generate epilepsy? Neuron 62(5):612\u2013632. doi: 10.1016\/j.neuron.2009.05.015","journal-title":"Neuron"},{"issue":"3","key":"1454_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/mol.110.069492","volume":"79","author":"P Bergson","year":"2011","unstructured":"Bergson P, Lipkind G, Lee SP, Duban ME, Hanck DA (2011) Verapamil block of T-type calcium channels. Mol Pharmacol 79(3):411\u2013419. doi: 10.1124\/mol.110.069492","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1454_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/mol.112.079715","volume":"82","author":"C Bladen","year":"2012","unstructured":"Bladen C, Zamponi GW (2012) Common mechanisms of drug interactions with sodium and T-type calcium channels. Mol Pharmacol 82(3):481\u2013487. doi: 10.1124\/mol.112.079715","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1454_CR9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0741-5214(99)70145-X","volume":"30","author":"LH Burns","year":"1999","unstructured":"Burns LH, Jin Z, Bowersox SS (1999) The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia. J Vasc Surg 30(2):334\u2013343","journal-title":"J Vasc Surg"},{"issue":"2","key":"1454_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(01)03029-3","volume":"919","author":"L Caputi","year":"2001","unstructured":"Caputi L, Hainsworth AH, Lavaroni F, Leach MJ, McNaughton NC, Mercuri NB, Randall AD, Spadoni F, Swan JH, Stefani A (2001) Neuroprotective actions in vivo and electrophysiological action in vitro of 202W92. Brain Res 919(2):259\u2013261","journal-title":"Brain Res"},{"key":"1454_CR11","volume":"4","author":"DW Chadwick","year":"2005","unstructured":"Chadwick DW, Marson AG (2005) Zonisamide add-on for drug-resistant partial epilepsy. Cochrane database Syst Rev 4, CD001416. doi: 10.1002\/14651858.CD001416.pub2","journal-title":"Cochrane database Syst Rev"},{"issue":"3","key":"1454_CR12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1152\/physrev.00010.2012","volume":"93","author":"E Cheong","year":"2013","unstructured":"Cheong E, Shin HS (2013) T-type Ca2+ channels in normal and abnormal brain functions. Physiol Rev 93(3):961\u2013992. doi: 10.1152\/physrev.00010.2012","journal-title":"Physiol Rev"},{"issue":"4","key":"1454_CR13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.3203-10.2011","volume":"31","author":"E Cheong","year":"2011","unstructured":"Cheong E, Kim C, Choi BJ, Sun M, Shin HS (2011) Thalamic ryanodine receptors are involved in controlling the tonic firing of thalamocortical neurons and inflammatory pain signal processing. J Neurosci Off J Soc Neurosci 31(4):1213\u20131218. doi: 10.1523\/JNEUROSCI.3203-10.2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"1\u20133","key":"1454_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2012.05.012","volume":"689","author":"ME Choudhury","year":"2012","unstructured":"Choudhury ME, Sugimoto K, Kubo M, Iwaki H, Tsujii T, Kyaw WT, Nishikawa N, Nagai M, Tanaka J, Nomoto M (2012) Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors. Eur J Pharmacol 689(1\u20133):72\u201380. doi: 10.1016\/j.ejphar.2012.05.012","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1454_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2011.06.015","volume":"44","author":"C Costa","year":"2011","unstructured":"Costa C, Tozzi A, Siliquini S, Galletti F, Cardaioli G, Tantucci M, Pisani F, Calabresi P (2011) A critical role of NO\/cGMP\/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide. Neurobiol Dis 44(2):185\u2013191. doi: 10.1016\/j.nbd.2011.06.011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1454_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1568026053386872","volume":"5","author":"AC Errington","year":"2005","unstructured":"Errington AC, Stohr T, Lees G (2005) Voltage gated ion channels: targets for anticonvulsant drugs. Curr Top Med Chem 5(1):15\u201330","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"1454_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.seizure.2011.04.005","volume":"20","author":"SH Eun","year":"2011","unstructured":"Eun SH, Kim HD, Eun BL, Lee IK, Chung HJ, Kim JS, Kang HC, Lee YM, Suh ES, Kim DW, Eom S, Lee JS, Moon HK (2011) Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure J Br Epilepsy Assoc 20(7):558\u2013563. doi: 10.1016\/j.seizure.2011.04.005","journal-title":"Seizure J Br Epilepsy Assoc"},{"issue":"24","key":"1454_CR18","doi-asserted-by":"crossref","first-page":"14469","DOI":"10.1073\/pnas.2437756100","volume":"100","author":"BS Finlin","year":"2003","unstructured":"Finlin BS, Crump SM, Satin J, Andres DA (2003) Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci U S A 100(24):14469\u201314474. doi: 10.1073\/pnas.2437756100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"1454_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2009.04.036","volume":"613","author":"T Furukawa","year":"2009","unstructured":"Furukawa T, Nukada T, Namiki Y, Miyashita Y, Hatsuno K, Ueno Y, Yamakawa T, Isshiki T (2009) Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes. Eur J Pharmacol 613(1\u20133):100\u2013107. doi: 10.1016\/j.ejphar.2009.04.036","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1454_CR20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.108.127548","volume":"53","author":"W Ge","year":"2009","unstructured":"Ge W, Ren J (2009) Combined L-\/T-type calcium channel blockers: ready for prime time. Hypertension 53(4):592\u2013594. doi: 10.1161\/HYPERTENSIONAHA.108.127548","journal-title":"Hypertension"},{"issue":"5","key":"1454_CR21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","volume":"60","author":"JC Gomora","year":"2001","unstructured":"Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E (2001) Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol 60(5):1121\u20131132","journal-title":"Mol Pharmacol"},{"issue":"18","key":"1454_CR22","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.1074\/jbc.M112.428128","volume":"288","author":"Y Gouriou","year":"2013","unstructured":"Gouriou Y, Bijlenga P, Demaurex N (2013) Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells. J Biol Chem 288(18):12459\u201312468. doi: 10.1074\/jbc.M112.428128","journal-title":"J Biol Chem"},{"key":"1454_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(03)01625-X","volume":"467","author":"AH Hainsworth","year":"2003","unstructured":"Hainsworth AH, McNaughton NC, Pereverzev A, Schneider T, Randall AD (2003) Actions of sipatrigine, 202 W92 and lamotrigine on R-type and T-type Ca+ 2 channel currents. Eur J Pharmacol 467:77\u201380","journal-title":"Eur J Pharmacol"},{"issue":"29","key":"1454_CR24","doi-asserted-by":"crossref","first-page":"21043","DOI":"10.1074\/jbc.M611809200","volume":"282","author":"ME Hildebrand","year":"2007","unstructured":"Hildebrand ME, David LS, Hamid J, Mulatz K, Garcia E, Zamponi GW, Snutch TP (2007) Selective inhibition of Cav3.3 T-type calcium channels by G alpha(q\/11)-coupled muscarinic acetylcholine receptors. J Biol Chem 282(29):21043\u201321055. doi: 10.1074\/jbc.M611809200","journal-title":"J Biol Chem"},{"issue":"16","key":"1454_CR25","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1517\/14656566.2011.622268","volume":"12","author":"JL Holder Jr","year":"2011","unstructured":"Holder JL Jr, Wilfong AA (2011) Zonisamide in the treatment of epilepsy. Expert Opin Pharmacother 12(16):2573\u20132581. doi: 10.1517\/14656566.2011.622268","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1454_CR26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2011.10.019","volume":"415","author":"T Hoshino","year":"2011","unstructured":"Hoshino T, Tabuchi K, Nishimura B, Tanaka S, Nakayama M, Ishii T, Warabi E, Yanagawa T, Shimizu R, Yamamoto M, Hara A (2011) Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity. Biochem Biophys Res Commun 415(1):94\u201398. doi: 10.1016\/j.bbrc.2011.10.019","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1454_CR27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tins.2007.05.007","volume":"30","author":"JR Huguenard","year":"2007","unstructured":"Huguenard JR, McCormick DA (2007) Thalamic synchrony and dynamic regulation of global forebrain oscillations. Trends Neurosci 30(7):350\u2013356. doi: 10.1016\/j.tins.2007.05.007","journal-title":"Trends Neurosci"},{"issue":"2","key":"1454_CR28","first-page":"126","volume":"4","author":"MC Iftinca","year":"2011","unstructured":"Iftinca MC (2011) Neuronal T-type calcium channels: what\u2019s new? Iftinca: T-type channel regulation. J Med Life 4(2):126\u2013138","journal-title":"J Med Life"},{"issue":"1","key":"1454_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","volume":"30","author":"MC Iftinca","year":"2009","unstructured":"Iftinca MC, Zamponi GW (2009) Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 30(1):32\u201340. doi: 10.1016\/j.tips.2008.10.004","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"1454_CR30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nn1921","volume":"10","author":"M Iftinca","year":"2007","unstructured":"Iftinca M, Zamid J, Chen L, Varela D, Tadayonnejad R, Altier C, Turner RW, Zamponi GW (2007) Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10(7):854\u2013860. doi: 10.1038\/Nn1921","journal-title":"Nat Neurosci"},{"key":"1454_CR31","unstructured":"Iftinca MC, Hamid J, Turner RW, Zamponi GW (2007) ROCK-mediated inhibition of T-type calcium channels. Biophysical journal:601a\u2013601a"},{"issue":"1\u20132","key":"1454_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-011-0913-3","volume":"358","author":"M Ishii","year":"2011","unstructured":"Ishii M, Iizuka R, Kiuchi Y, Mori Y, Shimizu S (2011) Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. Mol Cell Biochem 358(1\u20132):1\u201311. doi: 10.1007\/s11010-011-0913-3","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"1454_CR33","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","volume":"99","author":"MM Jagodic","year":"2008","unstructured":"Jagodic MM, Pathirathna S, Joksovic PM, Lee W, Nelson MT, Naik AK, Su P, Jevtovic-Todorovic V, Todorovic SM (2008) Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 99(6):3151\u20133156. doi: 10.1152\/jn.01031.2007","journal-title":"J Neurophysiol"},{"issue":"2","key":"1454_CR34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2010.06.058","volume":"481","author":"S Kawajiri","year":"2010","unstructured":"Kawajiri S, Machida Y, Saiki S, Sato S, Hattori N (2010) Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD. Neurosci Lett 481(2):88\u201391. doi: 10.1016\/j.neulet.2010.06.058","journal-title":"Neurosci Lett"},{"issue":"1","key":"1454_CR35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0896-6273(01)00343-9","volume":"31","author":"D Kim","year":"2001","unstructured":"Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS, McEnery MW, Shin HS (2001) Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 31(1):35\u201345","journal-title":"Neuron"},{"issue":"1\u20132","key":"1454_CR36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2009.03.003","volume":"251","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Park C, Han AL, Youn MJ, Lee JH, Kim Y, Kim ES, Kim HJ, Kim JK, Lee HK, Chung SY, So H, Park R (2009) Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res 251(1\u20132):70\u201382. doi: 10.1016\/j.heares.2009.03.003","journal-title":"Hear Res"},{"issue":"2","key":"1454_CR37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2007.05.011","volume":"53","author":"RL Kraus","year":"2007","unstructured":"Kraus RL, Li Y, Jovanovska A, Renger JJ (2007) Trazodone inhibits T-type calcium channels. Neuropharmacology 53(2):308\u2013317. doi: 10.1016\/j.neuropharm.2007.05.011","journal-title":"Neuropharmacology"},{"issue":"2","key":"1454_CR38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.110.171058","volume":"335","author":"RL Kraus","year":"2010","unstructured":"Kraus RL, Li Y, Gregan Y, Gotter AL, Uebele VN, Fox SV, Doran SM, Barrow JC, Yang ZQ, Reger TS, Koblan KS, Renger JJ (2010) In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. J Pharmacol Exp Ther 335(2):409\u2013417. doi: 10.1124\/jpet.110.171058","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"1454_CR39","first-page":"1","volume":"24","author":"L Lacinova","year":"2005","unstructured":"Lacinova L (2005) Voltage-dependent calcium channels. Gen Physiol Biophys 24(Suppl 1):1\u201378","journal-title":"Gen Physiol Biophys"},{"issue":"3","key":"1454_CR40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.braindev.2009.02.003","volume":"32","author":"YJ Lee","year":"2010","unstructured":"Lee YJ, Kang HC, Seo JH, Lee JS, Kim HD (2010) Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Brain Dev 32(3):208\u2013212. doi: 10.1016\/j.braindev.2009.02.003","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"1454_CR41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.heares.2011.05.010","volume":"278","author":"D Lei","year":"2011","unstructured":"Lei D, Gao X, Perez P, Ohlemiller KK, Chen CC, Campbell KP, Hood AY, Bao J (2011) Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel. Hear Res 278(1\u20132):106\u2013112. doi: 10.1016\/j.heares.2011.05.010","journal-title":"Hear Res"},{"issue":"12","key":"1454_CR42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00204-003-0498-z","volume":"77","author":"J Loikkanen","year":"2003","unstructured":"Loikkanen J, Naarala J, Vahakangas KH, Savolainen KM (2003) Glutamate increases toxicity of inorganic lead in GT1-7 neurons: partial protection induced by flunarizine. Arch Toxicol 77(12):663\u2013671. doi: 10.1007\/s00204-003-0498-z","journal-title":"Arch Toxicol"},{"issue":"1","key":"1454_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0309-1651(90)90066-8","volume":"14","author":"H Manev","year":"1990","unstructured":"Manev H, Favaron M, De Erausquin G, Guidotti A, Brooker G, Costa E (1990) Destabilization of ionized Ca2+ homeostasis in excitatory amino acid neurotoxicity: antagonism by glycosphingolipids. Cell Biol Int Rep 14(1):3\u201314","journal-title":"Cell Biol Int Rep"},{"issue":"2\u20133","key":"1454_CR44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2008.11.010","volume":"83","author":"N Matar","year":"2009","unstructured":"Matar N, Jin W, Wrubel H, Hescheler J, Schneider T, Weiergraber M (2009) Zonisamide block of cloned human T-type voltage-gated calcium channels. Epilepsy Res 83(2\u20133):224\u2013234. doi: 10.1016\/j.eplepsyres.2008.11.010","journal-title":"Epilepsy Res"},{"issue":"9","key":"1454_CR45","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1111\/j.1460-9568.2006.05136.x","volume":"24","author":"BE McKay","year":"2006","unstructured":"McKay BE, McRory JE, Molineux ML, Hamid J, Snutch TP, Zamponi GW, Turner RW (2006) Ca(V)3 T-type calcium channel isoforms differentially distribute to somatic and dendritic compartments in rat central neurons. Eur J Neurosci 24(9):2581\u20132594. doi: 10.1111\/j.1460-9568.2006.05136.x","journal-title":"Eur J Neurosci"},{"issue":"14","key":"1454_CR46","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1073\/pnas.0601261103","volume":"103","author":"ML Molineux","year":"2006","unstructured":"Molineux ML, McRory JE, McKay BE, Hamid J, Mehaffey WH, Rehak R, Snutch TP, Zamponi GW, Turner RW (2006) Specific T-type calcium channel isoforms are associated with distinct burst phenotypes in deep cerebellar nuclear neurons. Proc Natl Acad Sci U S A 103(14):5555\u20135560. doi: 10.1073\/pnas.0601261103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1454_CR47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/mol.104.010066","volume":"68","author":"I Nikonenko","year":"2005","unstructured":"Nikonenko I, Bancila M, Bloc A, Muller D, Bijlenga P (2005) Inhibition of T-type calcium channels protects neurons from delayed ischemia-induced damage. Mol Pharmacol 68(1):84\u201389. doi: 10.1124\/mol.104.010066","journal-title":"Mol Pharmacol"},{"issue":"7","key":"1454_CR48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.euroneuro.2011.05.004","volume":"21","author":"D Nutt","year":"2011","unstructured":"Nutt D, Goodwin G (2011) ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 21(7):495\u2013499. doi: 10.1016\/j.euroneuro.2011.05.004","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"3","key":"1454_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.108.051664","volume":"75","author":"P Orestes","year":"2009","unstructured":"Orestes P, Bojadzic D, Chow RM, Todorovic SM (2009) Mechanisms and functional significance of inhibition of neuronal T-type calcium channels by isoflurane. Mol Pharmacol 75(3):542\u2013554. doi: 10.1124\/mol.108.051664","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1454_CR50","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.bmc.2006.11.004","volume":"15","author":"JH Park","year":"2007","unstructured":"Park JH, Choi JK, Lee E, Lee JK, Rhim H, Seo SH, Kim Y, Doddareddy MR, Pae AN, Kang J, Roh EJ (2007) Lead discovery and optimization of T-type calcium channel blockers. Bioorg Med Chem 15(3):1409\u20131419. doi: 10.1016\/j.bmc.2006.11.004","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"1454_CR51","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.108.145672","volume":"328","author":"E Perez-Reyes","year":"2009","unstructured":"Perez-Reyes E, Van Deusen AL, Vitko I (2009) Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther 328(2):621\u2013627. doi: 10.1124\/jpet.108.145672","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1454_CR52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bmcl.2011.01.089","volume":"21","author":"TS Reger","year":"2011","unstructured":"Reger TS, Yang ZQ, Schlegel KA, Shu Y, Mattern C, Cube R, Rittle KE, McGaughey GB, Hartman GD, Tang C, Ballard J, Kuo Y, Prueksaritanont T, Nuss CE, Doran SM, Fox SV, Garson SL, Li Y, Kraus RL, Uebele VN, Renger JJ, Barrow JC (2011) Pyridyl amides as potent inhibitors of T-type calcium channels. Bioorg Med Chem Lett 21(6):1692\u20131696. doi: 10.1016\/j.bmcl.2011.01.089","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"1454_CR53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01193-X","volume":"335","author":"JC Rekling","year":"2003","unstructured":"Rekling JC (2003) Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen\/glucose deprivation. Neurosci Lett 335(3):167\u2013170","journal-title":"Neurosci Lett"},{"issue":"23","key":"1454_CR54","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.bmcl.2012.09.076","volume":"22","author":"HK Rim","year":"2012","unstructured":"Rim HK, Lee HW, Choi IS, Park JY, Choi HW, Choi JH, Cho YW, Lee JY, Lee KT (2012) T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells. Bioorg Med Chem Lett 22(23):7123\u20137126. doi: 10.1016\/j.bmcl.2012.09.076","journal-title":"Bioorg Med Chem Lett"},{"issue":"26","key":"1454_CR55","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1523\/JNEUROSCI.5668-03.2004","volume":"24","author":"B Salthun-Lassalle","year":"2004","unstructured":"Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, Michel PP (2004) Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci Off J Soc Neurosci 24(26):5922\u20135930. doi: 10.1523\/JNEUROSCI.5668-03.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"2","key":"1454_CR56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","volume":"22","author":"CM Santi","year":"2002","unstructured":"Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, Parker D, Stea A, Snutch TP (2002) Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci Off J Soc Neurosci 22(2):396\u2013403","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"6026","key":"1454_CR57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1126\/science.332.6026.174","volume":"332","author":"H Schellekens","year":"2011","unstructured":"Schellekens H, Moors E, Leufkens HG (2011) Drug regulatory systems must foster innovation. Science 332(6026):174\u2013175. doi: 10.1126\/science.332.6026.174","journal-title":"Science"},{"issue":"1\u20132","key":"1454_CR58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.heares.2006.12.011","volume":"226","author":"H Shen","year":"2007","unstructured":"Shen H, Zhang B, Shin JH, Lei D, Du Y, Gao X, Wang Q, Ohlemiller KK, Piccirillo J, Bao J (2007) Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. Hear Res 226(1\u20132):52\u201360. doi: 10.1016\/j.heares.2006.12.011","journal-title":"Hear Res"},{"issue":"11","key":"1454_CR59","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1016\/j.bmc.2008.03.051","volume":"16","author":"JA Shimshoni","year":"2008","unstructured":"Shimshoni JA, Bialer M, Yagen B (2008) Synthesis and anticonvulsant activity of aromatic tetramethylcyclopropanecarboxamide derivatives. Bioorg Med Chem 16(11):6297\u20136305. doi: 10.1016\/j.bmc.2008.03.051","journal-title":"Bioorg Med Chem"},{"issue":"1\u20132","key":"1454_CR60","first-page":"127","volume":"204","author":"HS So","year":"2005","unstructured":"So HS, Park C, Kim HJ, Lee JH, Park SY, Lee JH, Lee ZW, Kim HM, Kalinec F, Lim DJ, Park R (2005) Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hear Res 204(1\u20132):127\u2013139. doi: 10.1016\/j.heares.2005.01.011","journal-title":"Hear Res"},{"issue":"3","key":"1454_CR61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10162-008-0126-y","volume":"9","author":"H So","year":"2008","unstructured":"So H, Kim H, Kim Y, Kim E, Pae HO, Chung HT, Kim HJ, Kwon KB, Lee KM, Lee HY, Moon SK, Park R (2008) Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2\/HO-1. J Assoc Res Otolaryngol JARO 9(3):290\u2013306. doi: 10.1007\/s10162-008-0126-y","journal-title":"J Assoc Res Otolaryngol JARO"},{"issue":"22","key":"1454_CR62","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1523\/JNEUROSCI.5546-03.2004","volume":"24","author":"I Song","year":"2004","unstructured":"Song I, Kim D, Choi S, Sun M, Kim Y, Shin HS (2004) Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. J Neurosci Off J Soc Neurosci 24(22):5249\u20135257. doi: 10.1523\/JNEUROSCI.5546-03.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"2","key":"1454_CR63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2009.11.018","volume":"221","author":"PK Sonsalla","year":"2010","unstructured":"Sonsalla PK, Wong LY, Winnik B, Buckley B (2010) The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Exp Neurol 221(2):329\u2013334. doi: 10.1016\/j.expneurol.2009.11.018","journal-title":"Exp Neurol"},{"issue":"3","key":"1454_CR64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0166-2236(00)01738-0","volume":"24","author":"SC Stotz","year":"2001","unstructured":"Stotz SC, Zamponi GW (2001) Structural determinants of fast inactivation of high voltage-activated Ca(2+) channels. Trends Neurosci 24(3):176\u2013181","journal-title":"Trends Neurosci"},{"issue":"1","key":"1454_CR65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1085\/jgp.200709883","volume":"132","author":"H Sun","year":"2008","unstructured":"Sun H, Varela D, Chartier D, Ruben PC, Nattel S, Zamponi GW, Leblanc N (2008) Differential interactions of Na+ channel toxins with T-type Ca2+ channels. J Gen Physiol 132(1):101\u2013113. doi: 10.1085\/jgp.200709883","journal-title":"J Gen Physiol"},{"issue":"1","key":"1454_CR66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","volume":"20","author":"H Tanaka","year":"2002","unstructured":"Tanaka H, Shigenobu K (2002) Efonidipine hydrochloride: a dual blocker of L- and T-type Ca(2+) channels. Cardiovasc Drug Rev 20(1):81\u201392","journal-title":"Cardiovasc Drug Rev"},{"issue":"6","key":"1454_CR67","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1124\/mol.107.043612","volume":"73","author":"J Tao","year":"2008","unstructured":"Tao J, Hildebrand ME, Liao P, Liang MC, Tan G, Li S, Snutch TP, Soong TW (2008) Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels. Mol Pharmacol 73(6):1596\u20131609. doi: 10.1124\/mol.107.043612","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1454_CR68","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0026-895X(24)12624-7","volume":"60","author":"SM Todorovic","year":"2001","unstructured":"Todorovic SM, Jevtovic-Todorovic V, Mennerick S, Perez-Reyes E, Zorumski CF (2001) Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide. Mol Pharmacol 60(3):603\u2013610","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1454_CR69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/jn.1998.79.1.240","volume":"79","author":"SM Todorovic","year":"1998","unstructured":"Todorovic SM, Lingle CJ (1998) Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 79(1):240\u2013252","journal-title":"J Neurophysiol"},{"issue":"5","key":"1454_CR70","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.104.002402","volume":"66","author":"SM Todorovic","year":"2004","unstructured":"Todorovic SM, Pathirathna S, Brimelow BC, Jagodic MM, Ko SH, Jiang X, Nilsson KR, Zorumski CF, Covey DF, Jevtovic-Todorovic V (2004) 5Beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo. Mol Pharmacol 66(5):1223\u20131235. doi: 10.1124\/mol.104.002402","journal-title":"Mol Pharmacol"},{"issue":"6","key":"1454_CR71","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1124\/mol.105.020842","volume":"69","author":"A Traboulsie","year":"2006","unstructured":"Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P (2006) T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol 69(6):1963\u20131968. doi: 10.1124\/mol.105.020842","journal-title":"Mol Pharmacol"},{"issue":"Pt 1","key":"1454_CR72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1113\/jphysiol.2006.114496","volume":"578","author":"A Traboulsie","year":"2007","unstructured":"Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, Lory P (2007) Subunit-specific modulation of T-type calcium channels by zinc. J Physiol 578(Pt 1):159\u2013171. doi: 10.1113\/jphysiol.2006.114496","journal-title":"J Physiol"},{"issue":"5","key":"1454_CR73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/chan.5.5.16473","volume":"5","author":"RW Turner","year":"2011","unstructured":"Turner RW, Anderson D, Zamponi GW (2011) Signaling complexes of voltage-gated calcium channels. Channels 5(5):440\u2013448. doi: 10.4161\/chan.5.5.16473","journal-title":"Channels"},{"issue":"3","key":"1454_CR74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/WNR.0b013e3283200111","volume":"20","author":"VN Uebele","year":"2009","unstructured":"Uebele VN, Nuss CE, Santarelli VP, Garson SL, Kraus RL, Barrow JC, Stauffer SR, Koblan KS, Renger JJ, Aton S, Seibt J, Dumoulin M, Jha SK, Coleman T, Frank MG (2009) T-type calcium channels regulate cortical plasticity in-vivo. [corrected]. Neuroreport 20(3):257\u2013262. doi: 10.1097\/WNR.0b013e3283200111","journal-title":"Neuroreport"},{"issue":"1","key":"1454_CR75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1620\/tjem.218.41","volume":"218","author":"I Uemaetomari","year":"2009","unstructured":"Uemaetomari I, Tabuchi K, Nakamagoe M, Tanaka S, Murashita H, Hara A (2009) L-type voltage-gated calcium channel is involved in the pathogenesis of acoustic injury in the cochlea. Tohoku J Exp Med 218(1):41\u201347","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"1454_CR76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jth.12041","volume":"11","author":"HA Ham Van Den","year":"2013","unstructured":"Van Den Ham HA, Klungel OH, Leufkens HG, Van Staa TP (2013) The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. J Thromb Haemost JTH 11(1):107\u2013115. doi: 10.1111\/jth.12041","journal-title":"J Thromb Haemost JTH"},{"issue":"6","key":"1454_CR77","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1124\/mol.108.046961","volume":"73","author":"DL Varela","year":"2008","unstructured":"Varela DL, Hermosilla T, Zamponi GW (2008) Making the T-type even tinier: corticotropin-releasing factor-mediated inhibition of low-voltage-activated calcium channel activity. Mol Pharmacol 73(6):1589\u20131591. doi: 10.1124\/mol.108.046961","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1454_CR78","doi-asserted-by":"crossref","first-page":"e62942","DOI":"10.1371\/journal.pone.0062942","volume":"8","author":"X Wen","year":"2013","unstructured":"Wen X, Xu S, Liu H, Zhang Q, Liang H, Yang C, Wang H (2013) Neurotoxicity induced by bupivacaine via T-type calcium channels in SH-SY5Y cells. PloS One 8(5):e62942. doi: 10.1371\/journal.pone.0062942","journal-title":"PloS One"},{"key":"1454_CR79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-4-44","volume":"4","author":"NC Wildburger","year":"2009","unstructured":"Wildburger NC, Lin-Ye A, Baird MA, Lei D, Bao J (2009) Neuroprotective effects of blockers for T-type calcium channels. Mol Neurodegener 4:44. doi: 10.1186\/1750-1326-4-44","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1454_CR80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1073\/pnas.0135565100","volume":"100","author":"M Yoshida","year":"2003","unstructured":"Yoshida M, Ishikawa M, Izumi H, De Santis R, Morisawa M (2003) Store-operated calcium channel regulates the chemotactic behavior of ascidian sperm. Proc Natl Acad Sci U S A 100(1):149\u2013154. doi: 10.1073\/pnas.0135565100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1454_CR81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BRS.0b013e318272fbf8","volume":"38","author":"J Yue","year":"2013","unstructured":"Yue J, Liu L, Liu Z, Shu B, Zhang Y (2013) Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury. Spine 38(6):463\u2013470. doi: 10.1097\/BRS.0b013e318272fbf8","journal-title":"Spine"},{"issue":"6","key":"1454_CR82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/B:JOBB.0000008024.77488.48","volume":"35","author":"AM Yunker","year":"2003","unstructured":"Yunker AM, McEnery MW (2003) Low-voltage-activated (\u201cT-Type\u201d) calcium channels in review. J Bioenerg Biomembr 35(6):533\u2013575","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"1454_CR83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10571-012-9886-3","volume":"33","author":"VA Yurekli","year":"2013","unstructured":"Yurekli VA, Gurler S, Naziroglu M, Uguz AC, Koyuncuoglu HR (2013) Zonisamide attenuates MPP+ -induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells. Cell Mol Neurobiol 33(2):205\u2013212. doi: 10.1007\/s10571-012-9886-3","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"1454_CR84","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bbamem.2012.08.032","volume":"1828","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Jiang X, Snutch TP, Tao J (2013) Modulation of low-voltage-activated T-type Ca(2)(+) channels. Biochim Biophys Acta 1828(7):1550\u20131559. doi: 10.1016\/j.bbamem.2012.08.032","journal-title":"Biochim Biophys Acta"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-014-1454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-014-1454-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-014-1454-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T22:32:50Z","timestamp":1746138770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-014-1454-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s00424-014-1454-x","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}